{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:03:25Z","timestamp":1789380205519,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02489-3","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:15:00Z","timestamp":1786983300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential pathway profiles of uric acid and the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) in predicting incident type 2 diabetes: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Weiqiang","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"2489_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkebank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"24","key":"2489_CR2","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1001\/jama.2017.7596","volume":"317","author":"L Wang","year":"2017","unstructured":"Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515\u201323.","journal-title":"JAMA"},{"issue":"9","key":"2489_CR3","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Yachi Y, Sugawara A, Saito A, Sone H. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737\u201342.","journal-title":"Diabetes Care"},{"issue":"2","key":"2489_CR4","doi-asserted-by":"publisher","first-page":"e56864","DOI":"10.1371\/journal.pone.0056864","volume":"8","author":"Q Lv","year":"2013","unstructured":"Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, et al. High serum uric acid and increased risk of type 2 diabetes: a systematic review and meta-analysis of prospective studies. PLoS ONE. 2013;8(2):e56864.","journal-title":"PLoS ONE"},{"issue":"6","key":"2489_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","volume":"71","author":"RJ Johnson","year":"2018","unstructured":"Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, et al. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis. 2018;71(6):851\u201365.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2489_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3945\/jn.112.167221","volume":"143","author":"I Sluijs","year":"2013","unstructured":"Sluijs I, Beulens JW, van der A DL, Spijkerman AM, Schulze MB, van der Schouw YT, et al. Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr. 2013;143(1):80\u20135.","journal-title":"J Nutr"},{"key":"2489_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12916-024-03536-3","volume":"22","author":"B Yu","year":"2024","unstructured":"Yu B, Li M, Yu Z, Zheng T, Liu S, Feng Z, et al. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes. BMC Med. 2024;22:317.","journal-title":"BMC Med"},{"issue":"1","key":"2489_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12944-022-01682-2","volume":"21","author":"X Yang","year":"2022","unstructured":"Tan MY, Weng L, Yang ZH, Zhu SX, Wu S, Su JH. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: recent findings from NHANES 2007\u20132018. Lipids Health Dis. 2024;23(1):151.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"2489_CR9","first-page":"1118","volume":"31","author":"Q Lv","year":"2021","unstructured":"Liu C, Zhang Z, Meng T, Li C, Wang B, Zhang X. Cross-sectional analysis of non-HDL\/HDL cholesterol ratio as a marker for cardiovascular disease risk in middle-aged and older adults: Evidence from the CHARLS study. J Stroke Cerebrovasc Dis. 2025;34(1):108168.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2489_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12933-024-02149-7","volume":"23","author":"Y Zou","year":"2024","unstructured":"Han M, Li Q, Qie R, Guo C, Zhou Q, Tian G, et al. Association of non-HDL-C\/HDL-C ratio and its dynamic changes with incident type 2 diabetes mellitus: The Rural Chinese Cohort Study. J Diabetes Complications. 2020;34(12):107712.","journal-title":"Cardiovasc Diabetol"},{"key":"2489_CR11","first-page":"1385678","volume":"15","author":"J Li","year":"2024","unstructured":"Li B, Zha Y, Deng M, Niu L, Li X, Zhu R, et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of insulin resistance: results from the NHANES 2003\u20132016. BMC Endocr Disord. 2025;25(1):161.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2489_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev.nutr.24.012003.132155","volume":"25","author":"GM Reaven","year":"2005","unstructured":"Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr. 2005;25:391\u2013406.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"2489_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Zhang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"1 Suppl 1","key":"2489_CR14","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"American Diabetes Association","year":"2025","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2025;48(1 Suppl 1):S27\u201349.","journal-title":"Diabetes Care"},{"key":"2489_CR15","volume-title":"Explanation in Causal Inference: Methods for Mediation and Interaction","author":"TJ VanderWeele","year":"2015","unstructured":"VanderWeele TJ. Explanation in Causal Inference: Methods for Mediation and Interaction. New York: Oxford University Press; 2015."},{"issue":"3","key":"2489_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/er.2007-0023","volume":"29","author":"V Poitout","year":"2008","unstructured":"Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and \u03b2-cell dysfunction. Endocr Rev. 2008;29(3):351\u201366.","journal-title":"Endocr Rev"},{"key":"2489_CR17","doi-asserted-by":"publisher","first-page":"1275835","DOI":"10.3389\/fendo.2023.1275835","volume":"14","author":"P Thomas","year":"2023","unstructured":"Thomas P, Gallagher MT, Da Silva Xavier G. Beta cell lipotoxicity in the development of type 2 diabetes: the need for species-specific understanding. Front Endocrinol. 2023;14:1275835.","journal-title":"Front Endocrinol"},{"issue":"8","key":"2489_CR18","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.2337\/db14-0742","volume":"64","author":"I Sluijs","year":"2015","unstructured":"Sluijs I, Holmes MV, van der Schouw YT, Beulens JW, Asselbergs FW, Huerta JM, et al. A Mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes. 2015;64(8):3028\u201336.","journal-title":"Diabetes"},{"issue":"1","key":"2489_CR19","doi-asserted-by":"publisher","first-page":"e000834","DOI":"10.1136\/bmjdrc-2019-000834","volume":"8","author":"X Zhou","year":"2020","unstructured":"Keerman M, Yang F, Hu H, Zhang Y, Wang L, Wang M, et al. Mendelian randomization study of serum uric acid levels and diabetes risk: evidence from the Dongfeng-Tongji cohort. BMJ Open Diabetes Res Care. 2020;8(1):e000834.","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02489-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02489-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02489-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:09:05Z","timestamp":1789376945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02489-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02489-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Peking University (IRB00001052-11015). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"272"}}